RELIABILITY AND VALIDITY OF TWO PROXY VERSIONS OF EQ-5D-5L IN JAPAN

Author(s)

Noto S1, Igarashi A2, Shiroiwa T3, Fukuda T3, Ikeda S4, Moriwaki K5, Saito S6, Shimozuma K7, Ishida H8, Kobayashi M9
1Niigata University of Health and Welfare, Niigata, Japan, 2University of Tokyo, Tokyo, Japan, 3National Institute of Public Health, Wako, Japan, 4International University of Health and Welfare, Ohtawara, Japan, 5Kobe Pharmaceutical University, Kobe, Japan, 6Okayama University, Okayama, Japan, 7Ritsumeikan University, Kusatsu, Japan, 8Yamaguchi University Graduate School of Medicine, Ube, Japan, 9CRECON Medical Assessment Inc., Tokyo, Japan

OBJECTIVES: It aims to examine two proxy versions of EQ-5D-5L in Japanese for their reliability and validity METHODS: We compared various patient groups with use of EQ-5D-5L in Japanese version (Self-response version) and two proxy versions. In Proxy 1, a proxy will be asked how he/she would make an evaluation when evaluating a health condition for a subject. In Proxy 2, a proxy will be asked how it should be determined when a subject can communicate his/her own health condition. Proxy version evaluated an occupational therapist in charge. For the statistical processing, reliability and validity were calculated with Cronbach’s α coefficient and Pearson’s correlation coefficient respectively through using STATA14.0.

RESULTS: Total 251 patients became the subjects. The breakdown of disorders was 101 patients for cardiac disorder, 75 patients for respiratory disorder, 41 patients for cerebral tumor, and 34 patients for cervical myelopathy. 159 patients were female (63.3%). The mean scores of EQ-5D-5L were 0.739 (95%CI; 0.718-0.764) for Self-response, 0.735 (95%CI; 0.710-0.759) for Proxy 1, and 0.729 (95%CI; 0.705-0.754) for Proxy 2. α coefficient indicated 0.929 for Self-response/Proxy 1 and 0.956 for Self-response/Proxy 2. When verifying α coefficient with 3 scores by disorder, cardiac disorder (0.951), respiratory disorder (0.985), and cerebral tumor (0.912) indicated higher while cervical myelopathy (0.777) indicated lower. The correlation coefficient was 0.867 for Self-response/Proxy 1 and 0.952 for Self-response/Proxy 2.

CONCLUSIONS: We successfully clarified the reliability and validity for two proxy versions of EQ-5D-5L in Japanese. It was concerned that Proxy 2 may possibly estimate a patient’s QOL to be lower and the reliability would become less depending on disorder. Thus, it is required to give careful attention to those results when using Proxy versions.

Conference/Value in Health Info

2017-11, ISPOR Europe 2017, Glasgow, Scotland

Value in Health, Vol. 20, No. 9 (October 2017)

Code

PHP179

Topic

Patient-Centered Research

Topic Subcategory

Health State Utilities

Disease

Cardiovascular Disorders, Musculoskeletal Disorders, Oncology, Respiratory-Related Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×